Mumps outbreak spurs calls for a new vaccine

Health experts say that an outbreak of mumps two years ago among college students occurred even though most of them had received a recommended vaccine. And a number of physicians have concluded that that failure underscores the need for a new vaccine. In the meantime, adding a third dose of the currently used vaccine may be the best way to head off any renewed outbreak.

The outbreak in the Midwest hit thousands of people--making it the worst in almost 20 years. And 84 percent of the patients who knew for sure whether they had been vaccinated had been vaccinated against mumps, according to a study by the Centers for Disease Control and Prevention and state health departments. Researchers believe that a new strain of mumps that originated in the U.K. was probably responsible for the outbreak. 

"It may be time to be developing a new vaccine," Pam Shaw, a pediatrician at the University of Kansas Medical Center, tells the Kansas City Star.

- read the report for more

Related Articles:
Chiron pulls MMR vaccine off the market
WHO: Infectious disease a growing threat

Free Webinar

What could you do with real-time supply chain information at your fingertips?

Interested in complete supply chain real-time data visibility? Unlock productivity with digital workflows, manage plants inventory with real-time supply chain information and enable faster decision-making with data visualization with pci | bridge. Register today!

Suggested Articles

Implementing data integration strategy in your commercialization breaks down traditional healthcare silos and improves patient outcomes.

With COVID vaccinations expected to start in the coming weeks, 2021 is shaping up to be quite a year for the companies with leading vaccines.

The U.K. became the first Western country to authorize a COVID-19 vaccine, making the Pfizer/BioNTech shot the first mRNA vaccine for widespread use.